2,4-DIBROMO-ESTRA-1,3,5(10)-TRIENE-3,17.BETA.-DIOL-DI-TRIMETHYLSILYL ETHER
Compound with spectra: 1 MS (GC)
| SpectraBase Compound ID | HsYOpCqnwEC |
|---|---|
| InChI | InChI=1S/C24H38Br2O2Si2/c1-24-13-12-15-16(19(24)10-11-21(24)27-29(2,3)4)8-9-17-18(15)14-20(25)23(22(17)26)28-30(5,6)7/h14-16,19,21H,8-13H2,1-7H3/t15-,16+,19-,21-,24-/m0/s1 |
| InChIKey | OAGXUIBKCPUBRP-VWJPNKONSA-N |
| Mol Weight | 574.5 g/mol |
| Molecular Formula | C24H38Br2O2Si2 |
| Exact Mass | 572.07771 g/mol |
| Enantiomer InChIKey | OAGXUIBKCPUBRP-YLMPEHDVSA-N |
| Copyright | Copyright © 2011-2024 Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | Dr. Makin, London Hospital Medical College, UK |
- ((8R,9S,13S,14S,17S)-2,4-dibromo-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diyl)bis(oxy)bis(trimethylsilane)
- 2,4-DIBROMO-3,17-BIS[(TRIMETHYLSILYL)OXY]ESTRA-1(10),2,4-TRIENE
Silane, [[(17.beta.)-3-methoxyestra-1,3,5(10)-triene-4,7-diyl]bis(oxy)]bis[trimethyl-
2,4-DIBROMO-17.ALPHA.-ETHYNYL-ESTRA-1,3,5(10)-TRIENE-3,17.BETA.-DIOL
N-(Trimethylsilyl)-3,17-bis[(trimethylsilyl)oxy]estra-1(10),2,4-trien-2-amine
Acetic acid, 2,4-dibromo-7,8,9,11,12,13,14,15,16,17-decahydro-13-methyl-17-oxo-6H-cyclopenta[a]phenanthren-3-yl ester
4-[[(17-BETA)-17-HYDROXY-19-NORPREGNA-1,3,5(10)-TRIEN-3-YL]-OXY]-ESTRA-1,3,5(10)-TRIEN-3,17-BETA-DIOL
Silane, [[(16.alpha.,17.beta.)-estra-1,3,5(10)-triene-2,3,16,17-tetrayl]tetrakis(oxy)]tetrakis[trimethyl-
#5;N-[2-[[3,17-DIHYDROXY-4-[[2-[1-(4-HYDROXYPHENYL)-VINYLAMINO]-ETHYLIMINO]-METHYL]-13-METHYL-7,8,9,11,12,13,14,15,16,17-DECAHYDRO-6H-CYCLOPENTA-[A]-PHENANTHRE
4,4'-BIS-[ESTRA-1,3,5(10)-TRIEN-3,17-BETA-DIOL]
3,17.ALPHA.-DI[(TRIMETHYLSILYL)OXY]-ESTRA-1,3,5(10)-TRIENE-6-ONE(6-O-METHYLOXIME)
This compound is available in the following databases:
Mass Spectra of Physiologically Active Substances - including drugs, steroid hormones,and endocrine disruptors 2011
Author: Parr, Maria Kristina; Opfermann, Georg; Schänzer, Wilhelm; Makin, Hugh L. J.
Fast and reliable identification of trace steroids requires an up-to-date library covering most known and newly emerging steroids. It is updated annually. Learn more.